Page last updated: 2024-08-23
du-21220 and gabexate
du-21220 has been researched along with gabexate in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kaga, N; Katsuki, Y; Obata, M; Shibutani, Y | 1 |
Other Studies
1 other study(ies) available for du-21220 and gabexate
| Article | Year |
|---|---|
Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery.
Topics: Animals; Disease Models, Animal; Escherichia coli; Female; Gabexate; Glycoproteins; Humans; Indomethacin; Lipopolysaccharides; Mice; Mice, Inbred C3H; Obstetric Labor, Premature; Pregnancy; Ritodrine; Tocolytic Agents; Trypsin Inhibitors | 1996 |